title: Letter in reply to "Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations".
authors.affiliation: Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean-Verdier, Avenue du 14 Juillet, 93140 Bondy, France.|Université Paris XIII, 93000 Bobigny, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Sonigo
authors.affiliation: Department of Cytogenetic and Reproductive Biology, Hôpital Jean-Verdier, Avenue du 14 Juillet, 93140 Bondy, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Sermondade
authors.affiliation: Department of Reproductive Medicine & Fertility Preservation, Hôpital Jean-Verdier, Avenue du 14 Juillet, 93140 Bondy, France.|Université Paris XIII, 93000 Bobigny, France.|Unité Inserm U1133, Université Paris-Diderot, 75013 Paris, France.
authors.forename: Michaël
authors.initials: M
authors.lastname: Grynberg
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D005298:Fertility; D059247:Fertility Preservation / Q000379:methods; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007246:Infertility / Q000209:etiology; D054315:Oocyte Retrieval; D009865:Oocytes / Q000187:drug effects; D013997:Time Factors; D014747:Vinblastine / Q000009:adverse effects
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: Hodgkin lymphoma; fertility preservation; in vitro maturation